Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
Queensland Health

Generated: April 20, 2019

DrugPatentWatch Database Preview

Tentative Approvals for: lamivudine; zidovudine

« Back to Dashboard

lamivudine; zidovudine Drugs with Tentative Approvals

Applicant Generic Name NDA Strength Dosage Form
Aurobindo Pharma Ltd lamivudine; zidovudine; efavirenz 021943 150MG; 300MG; 600MG TABLET; ORAL
Macleods Pharma lamivudine; zidovudine 090679 150MG; 300MG TABLET; ORAL
Strides Acrolab lamivudine; zidovudine; efavirenz 022096 150MG; 300MG; 600MG TABLET; ORAL
Aurobindo Pharma Ltd lamivudine; zidovudine 022296 30MG; 60MG TABLET; ORAL
Emcure Pharma lamivudine; zidovudine 078929 150MG; 300MG TABLET; ORAL
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.